In 2,097 young adults surveyed annually from 2014 to 2019, living with someone who vaped went with 40% higher odds of bronchitis symptoms and 53% higher odds of breathlessness, after accounting for their own vaping and smoking.
Cigarette smoke announces itself. It stains, it lingers in fabric, and everyone in the room knows it happened. Vape aerosol mostly doesn’t, and that has let indoor vaping settle into houses and apartments without the argument that secondhand smoke eventually got. A study in Thorax suggests the argument is overdue.
What the study did
Talat Islam, Jessica Braymiller, Sandrah Eckel and colleagues at the University of Southern California followed 2,097 young adults in the Southern California Children’s Health Study: mean age 17.3 at the start, 50.4% male, 51.8% Hispanic white. Every year from 2014 to 2019 they filled out detailed surveys on respiratory symptoms and on who was vaping or smoking in their household. The paper was published online in Thorax in January 2022.
Bronchitic symptoms meant any of: bronchitis in the previous 12 months, a daily cough for three consecutive months, or congestion and phlegm that weren’t part of a cold. Wheeze meant self-reported wheezing or whistling in the chest in the past 12 months. Shortness of breath meant getting winded hurrying on level ground or walking up a slight hill.
Over the study years, secondhand nicotine vape exposure at home rose from 11.7% of participants to 15.6%, while secondhand cigarette smoke exposure fell from 27% to 21%. One indoor exposure was replacing another. Symptom prevalence moved as well: wheeze 12.3% to 14.9%, bronchitic symptoms 19.4% to 26.0%, shortness of breath roughly flat at 16.5% to 18.1%.
What they found
Bronchitic symptoms: adjusted OR 1.40. Shortness of breath: 1.53. Wheeze: no significant association. After controlling for the participant’s own vaping and smoking, active and passive tobacco and cannabis exposure, and demographics, secondhand nicotine vape exposure at home was associated with bronchitic symptoms (odds ratio 1.40, 95% CI 1.06-1.84) and shortness of breath (1.53, 95% CI 1.06-2.21). There was no significant association with wheeze once confounders were accounted for (Islam et al., 2022).
Those adjustments are the point. The comparison is not vapers against non-vapers; it is people with similar personal habits who differ in whether someone else vapes in their home.
The subgroup that matters most
The researchers then restricted the analysis to the 1,181 participants who reported no vaping and no smoking of their own in the past 30 days. That screen covers recent personal use rather than lifetime use, and the analysis still adjusts for other secondhand exposures, so it is not a pure secondhand-only group. The associations got stronger rather than weaker: compared with unexposed participants they were more than twice as likely to report wheeze, three times as likely to report bronchitic symptoms, and twice as likely to report shortness of breath, after adjusting for demographics and secondhand smoke and cannabis exposure. Those figures are reported as multiples rather than with confidence intervals, so they are best read as direction and rough magnitude.
Why this would happen
The authors state the mechanism directly: total particulate matter from e-cigarettes is lower than from combustible cigarettes, but the ultrafine particle concentration in e-cigarette aerosol can be higher than in cigarette smoke, “potentially delivering toxins to the distal airways and alveoli.” The aerosol also carries volatile aldehydes and oxidant metals, compounds already known to cause lung toxicity. Less total mass, smaller particles, deeper delivery. Ultrafine particles are the fraction that gets past the upper airway and settles in the small airways.
The limits, stated plainly
This is an observational cohort, so it cannot establish cause. Symptoms and exposures were self-reported and no home air measurements were taken. Between 76% and 93% of participants exposed to secondhand vaping were also using tobacco or cannabis themselves or exposed to secondhand smoke, which makes the exposures difficult to separate fully even after adjustment. It is one cohort, one region, one age band, and the wheeze finding did not survive adjustment. What survives the caveats: secondhand vape aerosol at home tracked with bronchitis symptoms and breathlessness, at a magnitude the authors describe as similar to what has been observed for secondhand cigarette smoke.
What gets lost in the marketing
The word “vapor” did a great deal of work in the lower-risk pitch. What comes off a heated coil is an aerosol, not steam: liquid droplets, ultrafine particles, aldehydes formed during heating, and trace metals from the hardware. On the cleanup side, an air purifier is not a fix for an indoor source. A true HEPA unit will capture particles while it runs, but it does nothing about the gas-phase compounds and cannot outrun someone exhaling in the next room. Ozone generators sold as smoke and odor “purifiers” are lung irritants rather than effective air cleaners, and the U.S. Environmental Protection Agency says so directly.
What the data supports
Vape and smoke outside rather than by an open window; source control beats every filter. If anyone in the household has asthma, COPD or a chronic cough, indoor vaping belongs on the list of triggers to remove before another medication is added. Run kitchen and bathroom exhaust fans and air the house out. A HEPA unit sized to the room helps with the particle fraction, and no one needs an ozone generator. And if symptoms consistently ease when someone is away from the house, the house is worth measuring.
Not sure what’s actually in your air? Measure it.
illumenair tests indoor air quality in Portland and Vancouver homes and rentals, so the conversation with a landlord, a housemate or a doctor starts from data instead of argument.
971-363-5626 · info@illumenair.com · www.illumenair.com
Sources: Islam T, Braymiller J, Eckel SP, et al. Secondhand nicotine vaping at home and respiratory symptoms in young adults. Thorax, published online 10 January 2022 (doi:10.1136/thoraxjnl-2021-217041). Fuentes AL, Crotty Alexander LE, linked editorial, Thorax, 2022. U.S. Environmental Protection Agency, guidance on ozone generators sold as air cleaners.